Montara Therapeutics, Inc.
Alex Laihsu is a Scientist at Montara Therapeutics, Inc., starting in January 2024, with prior experience as a Senior Research Associate at Gordian Biotechnology and in various research roles focusing on pharmacokinetics and therapeutic applications of small molecules for diseases such as Parkinson's and diabetes. Previous positions include Associate Scientist at Mitokinin Inc., where efforts targeted PINK1 small molecule activators, and Senior Research Associate at Achaogen, responsible for developing in vivo studies for antibacterial and vascular integrity assessments. Alex's research experience is complemented by a Bachelor’s Degree in Molecular Toxicology from the University of California, Berkeley, and an International Baccalaureate.
This person is not in any teams
Montara Therapeutics, Inc.
1 followers
We are Montara Therapeutics, a San Francisco–based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory Board (SAB). We bring a new approach to tackling challenging established targets, along with unique experience in developing enzyme activators and domain expertise in mitophagy. Our mission is to create innovative therapies for diseases of the CNS, with a focus on precision medicine and genetically validated targets to enhance drug safety and efficacy.